Concept information
Preferred term
Topotecan
Type
-
mesh:Descriptor
Definition
- An antineoplastic agent used to treat ovarian cancer. It works by inhibiting DNA TOPOISOMERASES, TYPE I.
Broader concept
Entry terms
- 119413-54-6 (Topotecan Hydrochloride)
- 123948-87-8 (Topotecan)
- 7M7YKX2N15
- 956S425ZCY
- 9-Dimethylaminomethyl-10-hydroxycamptothecin
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
119413-54-6 (Topotecan Hydrochloride)
-
123948-87-8 (Topotecan)
-
7M7YKX2N15
-
9-(Diméthylamino)méthyl-10-hydroxy-camptothécine
-
9-Diméthylaminométhyl-10-hydroxycamptothécine
-
956S425ZCY
-
Hycamtamine
URI
http://data.loterre.fr/ark:/67375/JVR-MHT7FTZQ-V
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}